A Chinese patient was hypersensitive to a therapeutic dose of suxamethonium because of a genetically determined quantitative and qualitative abnormality of plasma pseudocholinesterase.
INTRODUCTION
Suxamethonium was introduced into clinical use in 1951. It is still the relaxant of choice in general anaesthesia where profound muscle relaxation of short duration is required. Since 1952, there have been reports of prolonged apnoea following the use of suxamethonium due to lowered pseudocholinesterase (cholinesterase, acylcholine acyl-hydrolase, 3.1.1.8) levels in the serum (Bourne, Collier and Somers 1952 , Evans et al. 1952 , Forbat, Lehmann and Silk 1953 .
I t is now understood that abnormal responses to suxamethonium can be divided into three types:
(a) desensitization block as caused by high doses (0·5 g or more). (b) extended response following a therapeutic dose, lasting 10 to 20 minutes, as found in patients with liver disease, malnutrition, severe burns, haemodialysis, exposure to organophosphorous compounds, therapeutic irradiation and cancer chemotherapy. (c) prolonged response following a therapeutic dose, lasting up to 4 hours, due to an inherited abnormality of plasma (serum) pseudocholinesterase. So far, no clinical case of prolonged apnoea after suxamethonium has ever been documented in the Chinese population in Hong Kong, although it is estimated that at least 10,000
patients per year must have received this drug during general anaesthesia. There are several reasons. The causes of apnoea are usually complex: central depression, poor liver function malnutrition, electrolyte imbalance, acid-base disturbance, changes in excitability of nerve and muscle, and poor general condition of the patient may all be attributed as the cause of the apnoea. Sometimes a blood transfusion given to the patient at the time when suxamethonium is being administered may mask the suxamethonium sensitivity as it is well known that cholinesterase keeps well in stored bank blood. Furthermore, there is a definite possibility of variation in genetic inheritance in people of different ethnic groups. It is therefore of interest to record the following case which points to the existence of the Ch l D gene in the Chinese, although the incidence of its occurrence is still unknown.
CASE REPORT
A 31-year-old Chinese male hospital labourer, weighing 46 kg was admitted on January 6, 1976 for Lord's dilatation for haemorrhoids on the following day. The patient had been enjoying good health and physical examination showed no abnormality. His haemoglobin was 161gjlitre. Liver function tests, renal function tests and electrolytes were all within normal range.
Premedication consisted of atropine 0·6 mg and pethidine 50 mg given intramuscularly one hour before operation. Anaesthesia was induced with thiopentone sodium 250 mg intravenously and maintained with nitrous oxide and oxygen (5 and 2·5 LJmin. respectively) and halothane administered through a Magill attachment via a face mask. Respiration was spontaneous.
Blood pressure and pulse were stable throughout the anaesthetic. Recovery was uneventful and he was discharged home the next day.
The patient was readmitted on October 26, 1976 again for Lord's dilatation the following day. Premedication was the same as before. Anaesthesia was induced with thiopentone sodium 175 mg followed by suxamethonium chloride 50 mg intravenously. Nitrous oxide and oxygen were administered via a face mask. Respiration was controlled manually. The operation was over within 10 minutes. As the patient failed to show signs of return of spontaneous respiration as would normally be expected, he was intubated. Intermittent positive pressure ventilation was maintained with a Manley ventilator, using nitrous oxide and oxygen (Bourne 1953) . Apnoea altogether lasted one hour. All the time blood pressure and pulse were steady.
It was obvious that the apnoea could not have been due to central depression, since the central depressants given in this second anaesthetic had all been given in the previous one; in fact, the plane of anaesthesia was much lighter in this present anaesthetic as no volatile supplement was used. When eventually spontaneous respiratory activity returned, diaphragmatic movement was shallow and jerky. There was a tracheal tug. Nitrous oxide was turned off. Gradually respiratory excursions improved and the patient began to open his eyes and move his limbs feebly. He was then extubated. Further recovery was uneventful.
The patient was interrogated the next day. There was no history of insecticide exposure within the past four weeks, neither was there any history to suggest the presence of muscle disease. Heparinized blood was sent for estimation of cholinesterase. This was repeated 5 days later, giving the same biochemical findings. The patient's mother and sister were also investigated and the results are given in Table 1 . (Unfortunately the father, another sister and brother of the propositus were deceased.) DISCUSSION Two types of plasma pseudocholinesterase (normal and atypical) may be found in the serum of an individual, this being genetically determined. The normal enzyme is able to hydrolyse suxamethonium rapidly, whereas the atypical enzyme is incapable of doing so after a clinical dose of the drug. Thus a patient with a heterozygous type of enzyme activity will take longer than usual to complete the hydrolysis of the muscle relaxant, while a patient who is homozygous for the atypical enzyme will show a prolonged apnoea after a single therapeutic dose.
Many cholinesterase inhibitors (for example, dibucaine, sodium fluoride, Ro 2-0683, and some alkyl alcohols) have a differential inhibitory effect on the two types of serum pseudocholinesterase. Kalow and Genest (1957) used the inhibition caused by -5 log molar concentration of dibucaine as the basis for the screening test; the degree of inhibition, expressed as a percentage, was termed the " Dibucaine Number" (DN). The DN clearly differentiates three types of individuals. In a Canadian popUlation, Kalow and Staron (1957) have estimated that: Bush (1961) stated that there was a correlation between the three ranges of DN as described (Ellman, et. al., 1961) Ro 2-0683 Propositus (K.K.M.)
.. by Kalow and Genest (1957) and the three levels of pseudocholinesterase suggested by Lehmann, Patson and Ryan (1958) , although the apparent heterozygotes might have pseudocholinesterase levels which overlapped both the lower limit of the normal range and the value found in hypersensitive individuals. Indeed, in the heterozygote both the normal and the atypical forms of pseudocholinesterase may be found in the serum. Today, it is known that a number of other rarer genetic variants of plasma cholinesterase exist. This situation is typical of all genetic work on proteins (Lehmann and Liddell 1969) . Two genes are responsible for cholinesterase synthesis; in other words, there are two cholinesterase loci. At the first locus, there are four known variants: the usual gene, ChI u; the gene for the atypical dibucaineresistant enzyme, ChID; the gene for fluorideresistance, Ch 1 F (Harris and Whittaker 1961 ; and the silent gene, Ch I S (Liddell, Lehmann and Silk 1962 , Simpson and Kalow 1964 , Hodgkin et al. 1965 . At the second locus, there are two variants, the usual enzyme, Ch 2 -, and the C 5 variant, Ch 2 + .
The present case report points to the existence of the Ch I D gene in the Chinese population. This has never been demonstrated in the past. Vigilance on the part of the anaesthetist in the future, with biochemical backup, may allow the gene (abnormal) frequency of this abnormality to be estimated in people of this locality.
